Tweet by Dr. John Cush

Tweet
Dr. John Cush @RheumNow Oct 26, 2022
View on
#Gout clinic study of 223 gout pts on allopurinol ≥300 mg compared Pt & MD gout control assessments (0-10). Better agreement & higher scores seen w/o flares (3 or 12 mos) & SUA w/in target. Disagreement (22%) w/ recent flares & tophi
https://bit.ly/3Dq7K8m
Image from Dr. John Cush’s tweet

Related Content

Article Gout

Managing Gout in CKD Patients

Jack Cush, MD Mar 12, 2026
A current review article addressed the management of gout patients with chronic kidney disease (CKD).  This full read review addresses the epidemiology, challenges, treatment decisions and outcomes. The prevalence of gout rises with each stage of CKD; from 4%, 6% to 10%, 11% to 13%, and …
Article Gout

Uric Acid: Is Lower Better?

Joshua Baker, MD, MSCE Jul 6, 2026
Lowering serum urate and urate crystals in the body is indispensable for long-term management of gout. The pathophysiology is simple and powerful: no urate crystals, no gout flares. However, this simplicity in goal belies a nuanced consideration in management: how low should serum urate be…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×